Get informed when a big investor buys or sells
+ FollowLoading insider trades…
Loading congress trades…
| Market cap | $42.39 Million |
|---|---|
| Enterprise Value | - |
| Annual dividend | $1.97 |
| Dividend yield | 8.85% |
| Earnings per Share | $- |
| Beta | 4.11 |
| Outstanding Shares | - |
| P/E Ratio | - |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
No data
Compares institutional put options with call options. At 0.41, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.4067▼ 17.36% |
|---|---|
| Total Calls | 700,638▲ 29.72% |
| Total Puts | 284,920▼ 9.09% |
Holdings and activity of institutional investors.
| Ownership % | 18.07%▲ 11.39% |
|---|---|
| Total Invested | $16.60M▲ 467.37% |
| Investors Holding | 23▲ 5.00% |
Defiance Daily Target 2X Long HIMS ETF is an ETF incorporated in the United States. The Fund seeks daily leveraged investment results of two times the daily percentage change in the share price of Hims & Hers Health Inc. The Fund invests...
Stockcircle tracks 1 top investor with a current 13F position in Defiance Daily Target 2X Long HIMS ETF. Holdings come from the latest quarterly 13F filings filed with the SEC.
In the latest 13F quarter on Stockcircle, 1 top investor increased or opened positions among tracked top investors. Changes are based on reported share counts in their quarterly filings, not day-to-day trading.
Form 4 insider trades are added as new filings are imported. Top investor 13F holdings refresh after each quarterly filing cycle. Politician trade disclosures are added when new reports are published on Stockcircle.